• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Prostate-Specific Antigen screening of elderly men varies significantly in primary care

bys25qthea
October 16, 2013
in Chronic Disease, Oncology, Urology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. Primary care physicians accounted for 27% of the variance in whether an elderly man (>75 years old) received a PSA screen. 

2. Variance in PSA screening among elderly men attributable to PCPs (0.27) is higher than mammography (0.10) and colorectal cancer (0.09) screening. 

Evidence Rating Level: 3 (Average) 

Study Rundown: Prostate-specific antigen (PSA) screening has ignited significant controversy in recent years. For men 75 years or older, however, the medical community is generally in agreement: no PSA screening is recommended. Despite this, elderly men are still commonly screened in the community. This study identified the role of primary care physicians (PCP) in determining whether an older man received a PSA screen. The authors found a 10-fold difference in screening rates between the highest and lowest deciles of PCPs. In a model that evaluated PCP’s ordering of PSA testing, the intra-class correlation coefficient (ICC), which represents the percentage of variance attributable to the patient’s PCP, was 0.27. The ICC among PCPs for PSA screening stands in contrast to other studies that have demonstrated a ICC of 0.10 for mammography and 0.09 for colorectal cancer screening. This study is notable for a large sample size, but is limited due to analysis of data from a single year in only one state. Nonetheless, these findings suggest confusion among PCPs about the value of PSA screening in elderly men. Future research is needed to better characterize this high variability.

Click to read the study, published today as a Research Letter in JAMA

RELATED REPORTS

Pfizer’s Talzenna combo significantly delays prostate cancer progression

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

New model enhances prediction of prostate cancer-specific mortality

Relevant Reading: Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians

In-Depth [cross-sectional study]: This cross-sectional study identified 1,963 PCPs with patient panels that included 61,351 men aged 75 or older. The authors used Medicare Part A and B data for Texas in 2010 to conduct a multi-level, multi-variable logistic regression analysis and controlled for patient characteristics such as race/ethnicity, comorbidities, and Medicaid eligibility among others. Overall, 41% of men received PSA screening, of which 28.8% was ordered by their PCP. Screenings with PSA significantly decreased with age. The intra-class correlation coefficient (ICC) was 0.27, which means that 27% of the variance in PSA screening was attributed to the patient’s PCP. Patient characteristics such as age, comorbidities, or race/ethnicity accounted for only 3.7% of the observed variance.

By Jonathan Lichkus and Rif Rahman

More from this author: Younger women more likely than men to present with acute coronary syndrome without chest pain

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: prostate cancerPSA
Previous Post

Regular bedtime helps behavior in children

Next Post

In diabetics, coronary bypass surgery and percutaneous coronary intervention similar

RelatedReports

Radiation plus hormone therapy may improve prostate cancer survival
Oncology

Pfizer’s Talzenna combo significantly delays prostate cancer progression

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Testosterone replacement in male cancer survivors helps improve body composition
Oncology

New model enhances prediction of prostate cancer-specific mortality

January 12, 2026
Population-based risk factors and geographical trends identified for vitiligo
Oncology

Increasing cancer incidence rates in younger and older adults worldwide

October 20, 2025
Next Post
Remote ischemic preconditioning reduced myocardial injury in CABG patients

In diabetics, coronary bypass surgery and percutaneous coronary intervention similar

VATS lobectomy may be preferred in COPD with non-small-cell lung cancer

VATS lobectomy may be preferred in COPD with non-small-cell lung cancer

Sleeve gastrectomy surgery linked to more weight loss than lap-band

Deliberate practice in virtual reality simulator improves surgical resident performance

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Utah launches first in nation pilot for autonomous artificial intelligence prescription renewals
  • Sequential compared to upfront treatment of metastatic colorectal cancer using oxaliplatin (Eloxatin) therapy may lead to similar outcomes
  • Artificial intelligence decision support software improved spirometry diagnosis performance in primary care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.